- Home
- ADTX vs SBLX Comparison
ADTX vs SBLX Comparison
Compare ADTX & SBLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- SBLX
- Stock Information
- Founded
- ADTX 2017
- SBLX 2017
- Country
- ADTX United States
- SBLX United States
- Employees
- ADTX N/A
- SBLX N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- SBLX Telecommunications Equipment
- Sector
- ADTX Health Care
- SBLX Consumer Discretionary
- Exchange
- ADTX Nasdaq
- SBLX Nasdaq
- Market Cap
- ADTX 4.9M
- SBLX 4.0M
- IPO Year
- ADTX 2020
- SBLX N/A
- Fundamental
- Price
- ADTX $0.67
- SBLX $5.78
- Analyst Decision
- ADTX
- SBLX
- Analyst Count
- ADTX 0
- SBLX 0
- Target Price
- ADTX N/A
- SBLX N/A
- AVG Volume (30 Days)
- ADTX 342.1K
- SBLX 738.4K
- Earning Date
- ADTX 11-17-2025
- SBLX 11-13-2025
- Dividend Yield
- ADTX N/A
- SBLX N/A
- EPS Growth
- ADTX N/A
- SBLX N/A
- EPS
- ADTX N/A
- SBLX N/A
- Revenue
- ADTX $12,051.00
- SBLX $5,426.00
- Revenue This Year
- ADTX $15,768.94
- SBLX N/A
- Revenue Next Year
- ADTX N/A
- SBLX N/A
- P/E Ratio
- ADTX N/A
- SBLX N/A
- Revenue Growth
- ADTX N/A
- SBLX N/A
- 52 Week Low
- ADTX $0.67
- SBLX $4.20
- 52 Week High
- ADTX $464.98
- SBLX $15.28
- Technical
- Relative Strength Index (RSI)
- ADTX 26.68
- SBLX 55.53
- Support Level
- ADTX $0.97
- SBLX $4.85
- Resistance Level
- ADTX $0.77
- SBLX $6.33
- Average True Range (ATR)
- ADTX 0.07
- SBLX 0.45
- MACD
- ADTX -0.02
- SBLX 0.06
- Stochastic Oscillator
- ADTX 1.51
- SBLX 63.47
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
About SBLX StableX Technologies Inc. Common Stock
StableX Technologies Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.